Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Gore Range Capital is a specialized healthcare investment firm founded in 2015 and headquartered in New York. The firm is dedicated to building science-led platforms across various sectors, including precision health, regenerative medicine, personalized therapeutics, longevity, and restorative medical sciences. By combining the operational discipline of private equity with the scientific partnership model of venture investing, Gore Range Capital works closely with its portfolio companies to provide strategic, financial, and clinical guidance. This unique approach allows the firm to effectively support the development of innovative healthcare solutions that address critical health challenges.
Since its inception, Gore Range Capital has focused on investing in companies that are pioneering next-generation healthcare solutions aimed at tackling the root causes of aging, chronic disease, and functional decline. The firm has established a reputation for its commitment to scientific discovery and its ability to integrate clinical and commercial scalability into its investment strategy. With a strong emphasis on sectors such as biotech and healthcare, Gore Range Capital has positioned itself as a key player in the North American investment landscape.
Gore Range Capital invests in companies that are developing innovative healthcare solutions targeting the underlying causes of aging, chronic disease, and functional decline. The firm emphasizes investments in sectors such as biotech, healthcare, and longevity, with a particular focus on precision health, regenerative medicine, personalized therapeutics, and restorative medical sciences. By prioritizing innovations that integrate scientific discovery with clinical and commercial scalability, Gore Range Capital seeks to support companies that are poised to make significant advancements in healthcare.
A key area of focus for the firm is the skin, which serves as a biological gateway to health and longevity. This focus reflects Gore Range Capital's commitment to investing in technologies that not only address immediate health concerns but also promote long-term wellness and vitality. The firm typically invests at various stages, including Seed, Series A, Series B, and Growth Equity, allowing it to engage with companies at different points in their development journey. Gore Range Capital looks for founders and companies that demonstrate a strong scientific foundation, a clear path to commercialization, and the potential to create meaningful impact in the healthcare sector.
Gore Range Capital has a notable portfolio that includes several key investments and successful exits. One of the firm's most significant achievements is the sale of Novaestiq Corp. to Waldencast, which highlights its ability to identify and nurture promising healthcare companies. Additionally, Eirion Therapeutics is currently involved in a clinical trial for a potential breakthrough treatment for hair loss, showcasing the firm's commitment to supporting innovative solutions in the healthcare space. Another noteworthy portfolio company, Palvella Therapeutics, has received a grant from the U.S. Food and Drug Administration for its work in orphan products development, further underscoring the impact of Gore Range Capital's investments.
The firm's portfolio reflects its strategic focus on companies that are at the forefront of healthcare innovation, particularly in areas related to aging and chronic disease. By partnering with these companies, Gore Range Capital aims to drive advancements that can significantly improve patient outcomes and enhance the quality of life for individuals facing health challenges.
To pitch Gore Range Capital, visit their website at gorerangecapital.com. The firm welcomes pitches that clearly outline the business model, scientific foundation, and potential for commercialization. Founders should consider reaching out through the website for the best chance of engagement.
Gore Range Capital has been active in notable transactions and clinical developments within its portfolio. Recently, the firm facilitated the sale of Novaestiq Corp. to Waldencast, marking a significant exit. Additionally, Eirion Therapeutics is currently involved in a clinical trial for a potential breakthrough treatment for hair loss, showcasing the firm's commitment to supporting innovative healthcare solutions. Furthermore, Palvella Therapeutics received a grant from the U.S. Food and Drug Administration for its work in orphan products development, highlighting the impact of Gore Range Capital's investments in advancing healthcare technologies.
Gore Range Capital invests in multiple stages, including Seed, Series A, Series B, and Growth Equity. This diverse stage focus allows the firm to engage with companies at various points in their development journey, providing tailored support based on their specific needs.
The firm primarily focuses on the biotech and healthcare sectors, with a particular emphasis on longevity, precision health, regenerative medicine, and personalized therapeutics. This focus reflects Gore Range Capital's commitment to investing in next-generation healthcare solutions that address critical health challenges.
Founders interested in pitching Gore Range Capital can do so through their official website at gorerangecapital.com. It is advisable to provide a clear overview of the business model, scientific foundation, and potential for commercialization in the pitch.
Gore Range Capital primarily invests in North America. This geographic focus allows the firm to leverage its network and resources effectively within the region's healthcare ecosystem.
The specific check sizes are not detailed in the source material, but Gore Range Capital invests across various stages, which typically indicates a range of investment amounts depending on the stage and needs of the portfolio companies.
Gore Range Capital provides strategic, financial, and clinical guidance to its portfolio companies. This support is designed to help companies navigate the complexities of the healthcare landscape and enhance their chances of success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.